Human Gene ARID5B (ENST00000309334.5) from GENCODE V44
Description: Homo sapiens AT-rich interaction domain 5B (ARID5B), transcript variant 2, mRNA. (from RefSeq NM_001244638) RefSeq Summary (NM_001244638): This gene encodes a member of the AT-rich interaction domain (ARID) family of DNA binding proteins. The encoded protein forms a histone H3K9Me2 demethylase complex with PHD finger protein 2 and regulates the transcription of target genes involved in adipogenesis and liver development. This gene also plays a role in cell growth and differentiation of B-lymphocyte progenitors, and single nucleotide polymorphisms in this gene are associated with acute lymphoblastic leukemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Sep 2011]. Gencode Transcript: ENST00000309334.5 Gencode Gene: ENSG00000150347.17 Transcript (Including UTRs) Position: hg38 chr10:62,049,211-62,093,064 Size: 43,854 Total Exon Count: 7 Strand: + Coding Region Position: hg38 chr10:62,049,480-62,093,030 Size: 43,551 Coding Exon Count: 7
ID:ARI5B_HUMAN DESCRIPTION: RecName: Full=AT-rich interactive domain-containing protein 5B; Short=ARID domain-containing protein 5B; AltName: Full=MRF1-like protein; AltName: Full=Modulator recognition factor 2; Short=MRF-2; FUNCTION: Transcription coactivator that binds to the 5'-AATA[CT]- 3' core sequence and plays a key role in adipogenesis and liver development. Acts by forming a complex with phosphorylated PHF2, which mediates demethylation at Lys-336, leading to target the PHF2-ARID5B complex to target promoters, where PHF2 mediates demethylation of dimethylated 'Lys-9' of histone H3 (H3K9me2), followed by transcription activation of target genes. The PHF2- ARID5B complex acts as a coactivator of HNF4A in liver. Required for adipogenesis: regulates triglyceride metabolism in adipocytes by regulating expression of adipogenic genes. Overexpression leads to induction of smooth muscle marker genes, suggesting that it may also act as a regulator of smooth muscle cell differentiation and proliferation. Represses the cytomegalovirus enhancer. SUBCELLULAR LOCATION: Nucleus (By similarity). TISSUE SPECIFICITY: Widely expressed, including in liver (at protein level). DOMAIN: The ARID domain mediates the interaction with DNA. PTM: Methylation at Lys-336 prevents DNA-binding. Demethylation by PHF2 promotes recruitment of the PHF2-ARID5B complex to promoters. DISEASE: Note=Defects in ARID5B may be a cause of susceptibility to coronary atherosclerosis in the Japanese population. DISEASE: Defects in ARID5B may be a cause of susceptibility to acute lymphoblastic leukemia (ALL) [MIM:613065]. Note=ALL is a subtype of acute leukemia, a cancer of the white blood cells. ALL is a malignant disease of bone marrow and the most common malignancy diagnosed in children. The malignant cells are lymphoid precursor cells (lymphoblasts) that are arrested in an early stage of development. The lymphoblasts replace the normal marrow elements, resulting in a marked decrease in the production of normal blood cells. Consequently, anemia, thrombocytopenia, and neutropenia occur to varying degrees. The lymphoblasts also proliferate in organs other than the marrow, particularly the liver, spleen, and lymphonodes. SIMILARITY: Belongs to the ARID5B family. SIMILARITY: Contains 1 ARID domain. SEQUENCE CAUTION: Sequence=AAH15120.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence; Sequence=AAH36831.1; Type=Erroneous initiation; Note=Translation N-terminally shortened; Sequence=AAH66345.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence; Sequence=AAI07801.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence; Sequence=BAB15012.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence;
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on Q14865
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Gene Ontology (GO) Annotations with Structured Vocabulary
Molecular Function: GO:0000977 RNA polymerase II regulatory region sequence-specific DNA binding GO:0000981 RNA polymerase II transcription factor activity, sequence-specific DNA binding GO:0001227 transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding GO:0003677 DNA binding GO:0003713 transcription coactivator activity GO:0005515 protein binding GO:0032452 histone demethylase activity GO:0044212 transcription regulatory region DNA binding
Biological Process: GO:0000122 negative regulation of transcription from RNA polymerase II promoter GO:0001822 kidney development GO:0001889 liver development GO:0006351 transcription, DNA-templated GO:0006355 regulation of transcription, DNA-templated GO:0006807 nitrogen compound metabolic process GO:0008584 male gonad development GO:0008585 female gonad development GO:0009791 post-embryonic development GO:0010761 fibroblast migration GO:0016577 histone demethylation GO:0030325 adrenal gland development GO:0035264 multicellular organism growth GO:0045444 fat cell differentiation GO:0045892 negative regulation of transcription, DNA-templated GO:0048008 platelet-derived growth factor receptor signaling pathway GO:0048468 cell development GO:0048644 muscle organ morphogenesis GO:0048705 skeletal system morphogenesis GO:0051091 positive regulation of sequence-specific DNA binding transcription factor activity GO:0060021 palate development GO:0060325 face morphogenesis GO:0060612 adipose tissue development GO:0060613 fat pad development GO:1990830 cellular response to leukemia inhibitory factor
US Server
